Daptomycin for Children in Clinical Practice Experience

Silvia Garazzino, Elio Castagnola, Maria Di Gangi, Rita Ortolano, Andrzej Krzysztofiak, Agostino Nocerino, Susanna Esposito, Patrizia D'Argenio, Luisa Galli, Giuseppe Losurdo, Carmelina Calitri, P. A. Tovo, Roberto Bandettini, Salvatore Giordano, Piera Dones, Ottavio Ziino, Clara Mosa, Margherita Robazza, Claudia Tagliabue, Laura LancellaFrancesca Carraro

Research output: Contribution to journalArticlepeer-review


Data on daptomycin use in the pediatric setting are scanty. We conducted a multicenter, retrospective study on 46 children treated with intravenous daptomycin at a mean dosage of 7.0 mg/kg/day and for a median of 14 days. Three children had adverse events possibly related to daptomycin. The drug was overall well tolerated, even with prolonged treatment.

Original languageEnglish
Pages (from-to)639-641
Number of pages3
JournalPediatric Infectious Disease Journal
Issue number6
Publication statusPublished - 2016

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases
  • Microbiology (medical)


Dive into the research topics of 'Daptomycin for Children in Clinical Practice Experience'. Together they form a unique fingerprint.

Cite this